Drug intelligence / Profile preview

Lorect

Development stage
Unknown
Lead developer
Vorwarts Pharma
Modality
Small Molecules
Administration
Intranasal, Topical
01

Overview

Lorect is a hygienic-prophylactic nasal and throat spray developed by Farmstandart-Biolik and marketed by Vorwarts Pharma. It is formulated with Ectericid (products of the oxidation of fish oil) along with vitamins A, E, and D3. The active components, particularly carbonyl compounds formed during the oxidation of fish oil, exhibit local antiseptic and antimicrobial properties against common pathogens such as *Pseudomonas aeruginosa*, *Escherichia coli*, *Proteus* spp., *Staphylococcus* spp., and *Candida* fungi. Lorect is indicated for the relief of symptoms associated with acute and chronic inflammatory diseases of the nasopharynx and oral cavity, including rhinitis, sinusitis, tonsillitis, pharyngitis, and stomatitis, as well as for moisturizing and protecting the mucosal lining.

Brand names
LorectLorekt
Other names
Lorect sprayLorect-spreyLorekt sprayLorekt-sprey

Beyond the preview

Go deeper on Lorect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lorect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call